ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Eylea 2 mg/0.05 ml, Injektionslösung in einer Fertigspritze - 
62393002 PPBayer (Schweiz) AG
Eylea 2 mg/0.05 ml, Injektionslösung in einer Fertigspritze29.10.2012
  29.10.2012
Aflibercept (S01LA05) 
WHO-DDD 
11.99. 
11.99. 
B  
Yes 
IP 
845.90Yes
    
10 %936.40
  
7680623930026Biotechnologika
7755254 
Composition
afliberceptum 2 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 50 µl corresp. natrium 60 µg.
Packungsbestandteile
Lösung zur intravitrealen Injektion in einer Fertigspritze 
  
 
Active AgentDose
Afliberceptum2mg / 50µl
BAG: Active AgentDose
Afliberceptum2 mg
 
Inactive agents
Disodium Phosphate Heptahydrate
Sodium Chloride
Sodium Dihydrogenophosphate Monohydrate
Polysorbatum 20
Saccharum
 
Source
Data was imported : 12.03.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home